(4-(Cyclohexyl(methyl)carbamoyl)phenyl)boronic acid, 95.0%, 5g

5-Bromo-2-(hydroxymethyl)phenol, 95.0%, 10g

2-(6-Bromopyridin-2-yl)-2-methylpropanenitrile, 98%, 100mg

4-(2-HYDROXYETHYLAMINO)-2-(4-METHOXYPHENYLAMINO)-PYRIMIDINE HYDROCHLORIDE, 98%, 50mg

6-chloro-7-methyl-1H-indole-2,3-dione, 5g

1,2,3,4-Tetrahydroquinoline-6-carboxylic acid, 95.0%, 1g

4-(4-Methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde, 98% +(isomers mixture), 25g

5-(Trifluoromethyl)uracil, 97.0%, 5g

E-plan EPLi 10x/0.25 IOS infinity corrected objective

(2E)-1-(2-chlorophenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

2-(3-Methoxyprop-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

2-Cyclobutylpropanoic acid, 98+%, 5g

3,4-Difluorophenylacetic Acid>97.0%(GC)(T)1g